ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31

Zoetis Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$79.59+0.21 (+0.26%)

Close on Oct 19, 2026

Market cap: $33.24B
P/E (TTM): 13.1
Dividend yield: 2.55%

Zoetis Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31
Revenue	9,467	9,256	8,544	8,080	7,776	6,675	6,260	5,825	5,307	4,888	4,765	4,785	4,561	4,336	4,233
Cost of Revenue	2,666	2,719	2,561	2,454	2,303	2,057	1,992	1,911	1,775	1,666	1,738	1,717	1,669	1,563	1,652
Gross Profit	6,801	6,537	5,983	5,626	5,473	4,618	4,268	3,914	3,532	3,222	3,027	3,068	2,892	2,773	2,581
Research & Development	698	686	614	539	508	463	457	432	382	376	364	396	399	409	427
Selling, General & Admin	2,378	2,318	2,151	2,009	2,001	1,726	1,638	1,484	1,334	1,364	1,532	1,643	1,613	1,470	1,453
Advertising Expenses	308	302	281	287	292	233	167	158	154	119	106	132	143	141	134
Interest Expense	222	225	239	221	224	231	223	206	175	166	124	117	113	31	36
Other Non-Operating Income	36	19	159	-40	-48	-17	57	83	-6.00	2.00	-81	-7.00	9.00	46	-48
Merger & Restructuring Charges	49	43	46	6.00	33	8.00	33	26	13	2.00	301	17	5.00	52	–
Asset Impairment Charges	47	31	46	53	47	43	7.00	4.00	3.00	5.00	60	10	15	10	78
Gain (Loss) on Sale of Assets	-3.00	-23	101	0	-3.00	19	20	40	-11	26	0	9.00	6.00	0	0
Legal Settlements	–	–	–	–	–	–	0	0	8.00	-14	0	-10	-1.00	19	0
Pretax Income	3,360	3,133	2,936	2,656	2,488	1,996	1,801	1,690	1,525	1,228	545	820	690	710	394
Income Tax Expense	687	637	596	545	454	360	301	266	663	409	206	233	187	274	146
Net Income incl. Noncontrolling Interests	2,673	2,496	2,340	2,111	2,034	1,636	1,500	1,424	862	819	339	587	503	436	248
Minority Interest in Earnings	0	10	-4.00	-3.00	-3.00	-2.00	0	-4.00	-2.00	-2.00	0	4.00	-1.00	0	3.00
Net Income	2,673	2,486	2,344	2,114	2,037	1,638	1,500	1,428	864	821	339	583	504	436	245
EPS (Basic)(per share)	6.03	5.47	5.08	4.51	4.29	3.44	3.14	2.96	1.76	1.66	0.68	1.16	1.01	0.87	0.49
EPS (Diluted)(per share)	6.02	5.47	5.07	4.49	4.27	3.42	3.11	2.93	1.75	1.65	0.68	1.16	1.01	0.87	0.49
Shares Outstanding (Basic, Weighted)(shares)	443	454	461	469	474	476	478	483	490	496	500	501	500	500	500
Shares Outstanding (Diluted, Weighted)(shares)	444	455	462	470	477	479	482	487	493	498	502	502	500	500	500
Dividend per Share(per share)	2.03	1.80	1.56	1.35	1.08	0.85	0.69	0.54	0.44	0.39	0.34	0.30	0.27	0.00	0.00

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 71.5%
Operating margin: –
Net margin: 27.5%
Return on equity, FY2025: 65.3%

Financial strength

Current ratio: 3.08
Debt to equity: 2.87
Debt to assets: 60.0%
Cash to current liabilities: 71.6%

Valuation

P/E ratio: 13.1
Price to sales: 3.49
Price to book: 10.56
Dividend yield: 2.55%